News and Analysis

Evommune pulls in $83m Series A

Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, has secured $83 million in Series A financing.

-

Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, has secured $83 million in Series A financing. The investors included Andera Partners, LSP and Pivotal bioVenture Partners.

Source: Press Release